insights_auto
Why is EDIT down 2.81%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$2.11
arrow_downward
-2.81%(-0.061) 1D
$2.18
arrow_upward
+0.46% (+0.01)todayPre-market
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.10
High
$2.12
Low
$2.06
Mkt. cap
325.50M
Avg. vol.
2.44M
Volume
8.95K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$2.10
High
$2.12
Low
$2.06
Mkt. cap
325.50M
Avg. vol.
2.44M
Volume
8.95K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
CNBC
·
10 minutes ago
Morgan Stanley is out with its 2027 outlook for equities. Here’s what the bank expects
www.tokenpost.com
·
10 minutes ago
JPMorgan Projects S&P 500 Dividends to Grow 6.5% in 2026
The Motley Fool
·
2 hours ago
If You Had Invested $10,000 in the Vanguard S&P 500 ETF (VOO) in 2016, Here's What You Would Have Today
FXEmpire
·
1 hour ago
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com